Antiviral agents

PreclinicalSmall molecule

MMahidol University

Antiviral agents is one of 51 small molecule programs targeting Arthropathy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ArthropathyActive, not recruiting

Chronic HepatitisActive, not recruiting

ArthropathyPreclinical

Active, not recruiting

Chronic HepatitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

71 competitors in Chronic Hepatitis

#DrugCompanyPhaseTrials

PEG-Intron

Merck & Co.

Phase 3

43 2

Emtriva

Gilead

Approved

3 3

Glucophage

EMD Serono

Approved

1 4

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 5

Opdivo

Bristol-Myers Squibb

Phase 2

2 6

Pegylated Interferon Alfa

Merck & Co.

Phase 3

4 7

NA Therapy

GSK

Phase 3

2 8

AHB-137

AAusper Biopharma Co., Ltd.

Phase 3

3 9

Hydronidone

BBeijing Continent Pharmaceutical Co, Ltd.

Phase 3

2 10

Azvudine

HHenan Genuine Biotech Co., Ltd.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Recruiting

Pregnancy

NCT05013632

Clinical

Trials by Indication[1]

Chronic Hepatitis2 trials

Steatohepatitis in Chronic Hepatitis B

Completed·MMahidol University··NCT05317260·408 enrolled

Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B

Unknown status·ZZhongshan Hospital Xiamen University·N/A·NCT03429439·60 enrolled

Arthropathy1 trial

Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy

Unknown status·—··NCT03226717·100 enrolled

Pregnancy1 trial

COVID-19 International Drug Pregnancy Registry

Recruiting·PPregistry··NCT05013632·2,000 enrolled

Women1 trial

Women in Dual With Dolutegravir

Unknown status·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 3·NCT05735535·290 enrolled

Pneumonia1 trial

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Withdrawn·BBlessing Corporate Services, Inc·Phase 3·NCT04675086

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Antiviral agents. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Antiviral agents compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Antiviral agents. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mahidol University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMahidol University

Antiviral agents

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Chronic Hepatitis2 trials

Arthropathy1 trial

Pregnancy1 trial

Women1 trial

Pneumonia1 trial

References

Drug Info

Quick Facts

Related News